R-Ras belongs to a family of low molecular weight GTPbinding proteins and exhibits 55% amino acid identity to H-Ras. It has been demonstrated that H-Ras inhibits cell death caused by interleukin-3 (IL-3) withdrawal in BaF3 cells (Kinoshita et al. (1995b); Terada et al. (1995) ). In the present study, we examined whether R-Ras also rescues BaF3 cells from the factor-deprived cell death. To do this, several BaF3 transfectants were established, in which expression of wild-type as well as mutant R-Ras was regulated by an inducible promoter. Using these transfectants, we found that expression of an activated R-Ras mutant, R-Ras (Q87L), suppressed the death of IL-3-deprived BaF3 cells. On the other hand, expression of the wild-type and the dominant-negative mutant of RRas showed no inhibitory eect on cell death, indicating that R-Ras⋅GTP abrogated cell death caused by deprivation of IL-3. Furthermore, it was found that IGF-I in serum was required for the anti-apoptotic activity of R-Ras. Suppression of cell death by RRas(Q87L) was inhibited by wortmannin, LY294002 (phosphatidylinositol 3-kinase (PI3K) inhibitors), or PD98059 (inhibitor for MEK, a speci®c activator of mitogen-activated protein kinase (MAPK)). In addition, we have shown that, in HEK293 cells, R-Ras and IGF-I could activate MAPK synergistically. Also, PI3K activity was co-immunoprecipitated with an activated mutant of R-Ras. These results suggest that R-Ras in collaboration with IGF-I suppressed apoptotic cell death of BaF3 caused by IL-3 deprivation, presumably by modulating the activitites of MAPK and PI3K.
Introduction
Ras functions as a molecular switch in signal transduction regulating cellular proliferation and dierentiation (Barbacid, 1987; Kaziro et al., 1991; Lowy and Willumsen, 1993) . In mammals, three subtypes of Ras ± H-Ras, K-Ras and N-Ras ± have been identi®ed. A great number of studies have dealt with the mechanism of Ras-mediated signal transduction pathways from cell membrane receptors to gene expression in the nucleus. Ligand-induced activation of tyrosine kinase-linked receptors results in the recruitment of adaptor proteins such as Shc, Grb2 and Nck to the receptors. The Grb2⋅Sos complex is translocated to the plasma membrane, where Sos activates Ras through exchange of GDP bound to Ras with GTP (Schlessinger, 1993) . Then, Ras⋅GTP interacts with the serine/threonine kinase Raf, after which Raf is activated by a still unknown mechanism (Daum et al., 1994) . Activated Raf induces activation of mitogenactivated protein kinase kinase (MAPKK, also known as MEK), which in turn phosphorylates and activates mitogen-activated protein kinase (MAPK, also known as ERK) (Nishida and Gotoh, 1993) . Besides Raf, several eector molecules of Ras have been identi®ed, which include the guanine-nucleotide dissociation stimulator for Ral (Ral-GDS), MEK kinase, phosphatidylinositol 3-kinase (PI3K) and AF6 (Marshall, 1995; Kuriyama et al., 1996) .
The R-ras gene, highly homologous to H-ras, was originally isolated by low-stringency hybridization with a v-H-ras probe . R-Ras displays a high homology to H-Ras, and in particular, its putative eector region is almost identical with that of H-, Kand N-Ras. Therefore, it is possible that they share common target molecules. Indeed, R-Ras has been shown to interact with Raf and Ral-GDS (Rey et al., 1994; . Furthermore, R-Ras exhibits similar biological activities to H-, K-and N-Ras. For example, R-Ras induces MAPK phosphorylation, transcription from the Ras-responsive promoter element, and transformation of NIH3T3 cells (Cox et al., 1994; Saez et al., 1994) . On the other hand, R-Ras stimulates neither focus formation nor growth in soft agar of Rat-1 cells . R-Ras is incapable of inducing DNA synthesis in Swiss3T3 cells, neurite outgrowth in pheochromocytoma (PC)-12 cells, or germinal vesicle breakdown in Xenopus oocytes (Rey et al., 1994) . These ®ndings indicate that, in spite of the structural similarity, R-Ras does not mimic all the biological functions of H-, K-and N-Ras. Furthermore, it has recently been shown that R-Ras regulates integrin activity, while H-Ras does not (Zhang et al., 1996) . Taken together, though R-Ras and H-, K-and N-Ras may share some signaling pathways, they seem to regulate several distinct biological processes. It has been shown that H-Ras inhibits apoptotic death of hematopoietic cells upon cytokine deprivation (Kinoshita et al., 1995b; Terada et al., 1995) . Moreover, it has been reported that R-Ras associates with Bcl-2, an anti-apoptotic protein (Fernandez-Sarabia and Bischo, 1993) . These reports have raised the possibility that R-Ras may play a role in the regulation of cell death. Here, we examined the eect of R-Ras on the death of BaF3 cells in response to cytokine depletion and found that R-Ras suppressed cell death. In contrast to H-Ras, suppression by R-Ras requires the presence of IGF-I. The possible involve-ment of PI3K and MAPK in an anti-apoptotic function of R-Ras and IGF-I was suggested.
Results

Eect of R-Ras mutants on cell death of BaF3 induced by IL-3 deprivation
BaF3 is an interleukin-3 (IL-3)-dependent mouse pro-B cell line, which undergoes rapid apoptosis on removal of IL-3 from the culture medium. To study the function of R-Ras in BaF3 cells, we established several stable BaF3 transfectants, in which expression of the wild type, a dominant-negative mutant (S43N), or a constitutively activated mutant (G38V or Q87L) of mouse R-Ras was induced by addition of isopropyl b-D-thiogalactopyranoside (IPTG) to medium. Figure 1 shows expression of R-Ras mutants in two representative clones, Lh9 and Nc7, which inducibly express RRas(Q87L) and R-Ras(S43N), respectively. In each case, expression of the mutant protein was detected at 3 h after IPTG treatment and reached a plateau at 12 h. Using these clones, we examined the eect of RRas mutants on the cell death of BaF3 upon IL-3 deprivation.
For IL-3 depletion, cells were transferred from the culture medium into the IL-3-free medium, RPMI1640 containing 10% serum and cultured in the presence or absence of IPTG. At various intervals, the number of viable cells was quantitated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. In the absence of IPTG, IL-3-deprived Lh9 cells could not survive and the number of viable cells rapidly decreased (Figure 2a, open circles) . On the other hand, the presence of IPTG in the IL-3-free medium remarkably suppressed the decrease of viable Lh9 cells ( Figure 2a , closed circles), suggesting that expression of R-Ras(Q87L) sustained cell survival. Similar results were obtained with R-Ras(G38V) (data not shown). In contrast, in the case of Nc7 cells, IPTG-induced expression of R-Ras(S43N) did not exhibit any eect on the rate of decrease of viable cells (Figure 2b ). The wild-type R-Ras also failed to inhibit cell death (data not shown). To exclude the possibility of clonal variation, we performed the same experiment with multiple independent clones and obtained similar results. It is assumed that RRas(G38V) and R-Ras(Q87L) are present in cells mostly in the GTP-bound form, while the wild-type R-Ras and R-Ras(S43N) are in the GDP-bound form. We therefore conclude that R-Ras⋅GTP can suppress cell death of IL-3-deprived BaF3 cells.
We also examined the eect of R-Ras(Q87L) expression on fragmentation of chromosomal DNA, a Although some fragmentation of DNA was detected even in IPTG-treated cells, the magnitude of the fragmentation was similar to that in the case of IL-4 treatment (data not shown), which has been reported to suppress apoptosis of BaF3 cells (RodriguezTarduchy et al., 1992a) . These results suggest that RRas(Q87L) inhibits apoptosis.
Requirement of IGF-I for R-Ras-dependent prevention of cell death
Since R-Ras(Q87L)-expressing cells were able to survive in the IL-3-free medium, we tested whether the fetal bovine serum added to the IL-3-free medium was dispensable for R-Ras-induced inhibition of the cell death. For this purpose, Lh9 cells were cultured for 36 h in either the IL-3-free medium or the`serum-free' medium (see Materials and methods) containing neither IL-3 nor serum. As shown in Figure 4a , RRas(Q87L) could not rescue BaF3 cells in the absence of serum, suggesting that some factor(s) in fetal bovine serum is required for R-Ras(Q87L) to inhibit cell death. Then, we attempted to identify such serum factor(s). The ®rst candidates were integrin ligands including ®bronectin, laminin and vitronectin, as it has recently been reported that R-Ras regulates the ligand-binding activity of integrin (Zhang et al., 1996) . However, addition of these molecules into the serum-free medium could not prevent the death of IL-3-deprived RRas(Q87L)-expressing BaF3 cells (data not shown). We tested the eect of insulin-like growth factor-I (IGF-I), which was reported to inhibit apoptosis of BaF3 cells at a higher concentration (500 ng/ml) (Rodriguez-Tarduchy et al., 1992b) , and found that this growth factor eectively substituted for serum. In the serum-free medium, though neither R-Ras(Q87L) alone nor IGF-I (20 ng/ml) alone was able to suppress cell death, a combination of the two eectively rescued BaF3 cells from apoptosis ( Figure 4b ). Moreover, RRas-induced survival was completely abolished by neutralization of IGF-I in serum with an anti-IGF-I antibody ( Figure 4c ). These observations indicate that IGF-I was the serum factor required for the suppression of cell death by R-Ras.
Inhibition of R-Ras-induced survival of BaF3 by inhibitors against PI3K and MEK
Several cellular molecules such as MAPK and PI3K have been identi®ed as suppressors of cell death. To assess whether these molecules play a critical role in the R-Ras-dependent survival of BaF3 cells, we studied the eect of inhibitors. PD98059 is a speci®c inhibitor against MEK (Dudley et al., 1995) . Since MEK is so far the only known protein that speci®cally phosphorylates and activates MAPK, inhibition of MEK activity should lead to the suppression of MAPK activation. As expected, PD98059 completely inhibited IL-3-induced MAPK phosphorylation at a concentration of 20 mM (data not shown). When cells were treated with 20 mM of PD98059, suppression of cell death by R-Ras(Q87L) was partially blocked ( Figure  5a ). The decrease of the cell viability by PD98059 was not due to the cytotoxic eect of the drug, as this inhibitor did not aect the IL-3-dependent growth of BaF3 cells at the same concentration (data not shown). When wortmannin, a speci®c inhibitor of PI3K (Ui et al., 1995) , was added to the medium at a ®nal concentration of 100 nM, the anti-apoptotic eect of R-Ras(Q87L) was almost completely inhibited ( Figure  5b ). PI3K activity was entirely suppressed at this concentration, although the IL-3-dependent growth was not aected (data not shown). Similar results were obtained with another PI3K-speci®c inhibitor, LY294002 (Vlahos et al., 1994) (data not shown). These results suggest that both PI3K and MAPK are required for R-Ras-dependent prevention of cell death.
Possible involvement of PI3K and MAPK in the R-Rasmediated signaling pathway
The signaling pathway involving R-Ras has not yet been well characterized. The results described in the preceding section suggest that MAPK and PI3K may play an important role in the R-Ras-dependent prevention of BaF3 cell death. Therefore, we examined whether these kinases participate in R-Rasmediated signal transduction, using the transient expression system with human embryonic kidney (HEK) 293 cells. As shown in Figure 6a , the expression of R-Ras(Q87L) caused activation of MAPK, while that of the wild-type R-Ras did not. Immunoblot analysis with an anti-R-Ras antibody revealed that the expression levels of R-Ras(Q87L) and R-Ras were practically the same (data not shown). Thus, the results suggest that R-Ras⋅GTP activates MAPK, in agreement with the previous report (Cox et al., 1994 ) that R-Ras induces MAPK phosphorylation. Then we investigated whether IGF-I can enhance RRas-induced activation of MAPK. The results shown in Figure 6b indicate that MAPK activation by RRas(Q87L) was greatly potentiated by IGF-I, although either IGF-I or R-Ras(Q87L) alone induced only a slight activation of MAPK. It has been shown that H-Ras interacts with PI3K through its eector region (Rodriguez-Viciana et al., 1994) . Since R-Ras and H-Ras have a similar amino acid sequence at the eector region, it is possible that R-Ras may also interact with PI3K. We therefore tested whether the PI3K activity was co-immunoprecipitated with R-Ras. HEK293 cells were transfected with an empty vector (for mock transfection) or the expression plasmid for FLAG-R-Ras (R-Ras with FLAG-epitope tag in its N-terminus), or FLAG-RRas(Q87L), starved for one day and lysed to perform immunoprecipitation with an anti-FLAG antibody. After washing, the level of the PI3K activity in immunoprecipitates was measured. As shown in . Viable cells were measured as described in Figure 2 and the values are expressed as the mean+s.e. of at least three separate experiments Figure 7 , a signi®cantly higher PI3K activity was coprecipitated with FLAG-R-Ras(Q87L). On the other hand, FLAG-R-Ras was unable to associate with PI3K activity, although its expression level was comparable to that of FLAG-R-Ras(Q87L) (data not shown). These results suggest that R-Ras associates with PI3K and this association occurs in a GTP-dependent manner. 
Discussion
In this paper, we demonstrated that, in the presence of serum, the GTP-bound form of R-Ras suppressed cell death of BaF3 caused by IL-3 deprivation and that IGF-I in serum was required for this suppression. The results of the experiments utilizing speci®c inhibitors suggest that PI3K and MAPK are involved in the suppression. In addition, the transient expression system using HEK293 cells shows that R-Ras and IGF-I synergistically induce MAPK activation and that R-Ras is associated with PI3K activity. Taken together, it is likely that R-Ras in cooperation with IGF-I inhibits the cell death of BaF3 induced by IL-3 deprivation, through the activation of PI3K and MAPK.
Inhibition of internucleosomal DNA fragmentation by R-Ras(Q87L) indicates that R-Ras functions as a suppressor of apoptosis in BaF3 cells. Since the suppression of DNA degradation by R-Ras was incomplete, it is likely that some cells underwent apoptosis. MTT assay showed that the number of viable cells remained unchanged, and microscopically, we observed some dividing cells, although most of the cells appeared quiescent (data not shown). These results suggest that R-Ras may induce proliferation of BaF3 cells, in addition to its anti-apoptotic eect. This idea is consistent with the previous result that RRas has transforming capacity in NIH3T3 cells (Cox et al., 1994; Saez et al., 1994) . We tried to examine this concept by investigating whether R-Ras(S43N) inhibits the growth of BaF3 cells using Nc7 cells. By analogy with Ras(S17N), R-Ras(S43N) was expected to block the activation of endogenous R-Ras and function as a dominant-negative mutant. However, overexpression of this mutant did not aect the proliferation of BaF3 cells in the presence of IL-3 (data not shown). Thus, the function of R-Ras seems to be dispensable for the IL-3-induced proliferation of BaF3 cells, although we do not know whether R-Ras(S43N) actually interfered with the activation of endogenous R-Ras under our experimental conditions.
The ability of R-Ras(Q87L) to support the survival of BaF3 cells was almost completely lost by PI3K inhibitors, suggesting that the function of R-Ras to suppress cell death requires PI3K activity. This is in agreement with the previous ®ndings that PI3K is required for prevention of the cell death in several hematopoietic cell lines (Scheid et al., 1995; Minshall et al., 1996) and PC-12 cells (Yao and Cooper, 1995) . Recently, a serine/threonine kinase, Akt/PKB, has been reported to function as a downstream molecule of PI3K (Franke et al., 1997) . Since expression of a catalytically active Akt/PKB mutant inhibits apoptosis of BaF3 cells upon IL-3 deprivation (Ahmed et al., 1997) , PI3K probably rescued BaF3 cells from apoptosis through Akt/PKB activation.
Several growth factors or cytokines which suppress cell death are known to activate MAPK (Cobb et al., 1991) . In addition, it was reported that activation of MAPK results in inhibition of cell death caused by withdrawal of nerve growth factor in PC-12 cells (Xia et al., 1995) . These results suggest the importance of MAPK activation for cell survival. The experiments using a MEK inhibitor PD98059 suggest that MAPK was required also for R-Ras-induced survival in BaF3 cells. However, PD98059, in contrast to PI3K inhibitors, showed only a partial inhibition at a concentration of 20 mM. We consider it unlikely that R-Ras-induced MAPK activation was not completely suppressed by 20 mM of PD98059, because this concentration was sucient to inhibit activation of MAPK induced by IL-3, a much stronger inducer of MAPK activation than the combination of RRas(Q87L) and IGF-I in BaF3 cells (data not shown). Therefore, it seems that R-Ras-induced survival of BaF3 cells exhibited a dierent dependency between PI3K and MAPK.
While inhibitors for MEK and PI3K blocked RRas-induced survival, they showed no eect on the IL-3-induced proliferation of BaF3 cells. It is known that, in addition to the activation of the two kinases, IL-3 activates other signaling pathways such as the JAK-STAT (Janus kinase-Signal transducers and activators of transcription) pathway (Silvennoinen et al., 1993) and the pathway that leads to c-Myc expression (Conscience et al., 1986) . Thus, in the case of IL-3, it is possible that the survival of BaF3 cells may be supported by multiple pathways.
We observed the association of PI3K activity with R-Ras(Q87L) in HEK293 cells. Our data cannot rule out the possibility that the molecule associated with RRas may not be PI3K itself, but other proteins with similar activities, and it is unclear whether the interaction was direct or indirect through other components. Nonetheless, considering the close resemblance of the amino acid sequence between H-Ras and R-Ras in the eector region, through which H-Ras interacts with PI3K, it is highly possible that R-Ras interacts directly with PI3K. If so, since PI3K is activated through interaction with H-Ras by itself in vitro (Rodriguez-Viciana et al., 1996) , the interaction with R-Ras may also induce PI3K activation. Association of PI3K activity with the GTP-bound form of R-Ras. HEK293 cells were transfected with pCMV5 (2 mg), pCMV5-FLAG-R-Ras(Q87L) (2 mg) or pCMV5-FLAG-R-Ras (1.5 mg). After starvation, cells were lysed and FLAG-R-Ras was immunoprecipitated with the anti-FLAG antibody. Immunoprecipitates were subjected to PI3K assay as described in Materials and methods. Relative PI3K activities as the mean+s.e. (n=3) are shown Although the present study demonstrated the synergistic anti-apoptotic eect of R-Ras and IGF-I in BaF3 cells, its molecular mechanism remains unclear. We assume that R-Ras and IGF-I probably activate MAPK synergistically in BaF3 cells, as well as in HEK293 cells. Furthermore, since R-Ras binds to Raf, an upstream molecule of MAPK, and IGF-I stimulates Raf kinase activity (LeRoith et al., 1995) , it is most likely that the synergistic activation of MAPK by R-Ras and IGF-I is mediated through Raf. Another possibility is that MAPK is activated through PI3K as reported in some systems (Hu et al., 1995; Karnitz et al., 1995) . As for PI3K, we do not know whether RRas and IGF-I induce synergistic enhancement of its kinase activity. However, PI3K may be activated synergistically by R-Ras and IGF-I, because H-Rasinduced PI3K activation is potentiated by the presence of phosphotyrosine-containing peptides (RodriguezViciana et al., 1996) and IGF-I induces tyrosine phosphorylation of several cellular proteins (LeRoith et al., 1995) . In addition, H-Ras may be involved in RRas-induced survival of BaF3 cells in the presence of IGF-I because IGF-I is reported to activate H-Ras (LeRoith et al., 1995) and H-Ras displays an antiapoptotic eect on BaF3 cells (Kinoshita et al., 1995b; Terada et al., 1995) . It is also possible that other molecule(s) than PI3K and MAPK are also required for cell death suppression by R-Ras. These possibilities will be explored in future work.
It was reported that the activated mutant of H-Ras exhibits an anti-apoptotic eect on BaF3 cells even in the serum-free medium (Kinoshita et al., 1995a) . Thus, though both R-Ras and H-Ras protected BaF3 cells from apoptotic death, the eect of R-Ras diers from H-Ras in its requirement for IGF-I in serum. Since HRas activates PI3K and MAPK (Lowy and Willumsen, 1993; Rodriguez-Viciana et al., 1996) , the most likely explanation for this dierence is that H-Ras by itself can activate PI3K and MAPK strongly enough to suppress apoptosis in the serum-free medium, whereas R-Ras requires costimulation by IGF-I to induce activation of PI3K and MAPK. This idea was supported by the observation that, in HEK293 cells, though either R-Ras(Q87L) or IGF-I alone induced only a mild increase of MAPK activity, the combination of R-Ras(Q87L) and IGF-I resulted in strong activation of MAPK. Wang et al. (1995) reported that R-Ras promotes apoptotic death of IL-3-deprived 32D myeloid cells and also serum-deprived NIH3T3 ®broblast cells. Promotion of cell death by R-Ras was inhibited by overexpression of Bcl-2, suggesting that R-Ras promotes the cell death via a pathway which can be suppressed by Bcl-2. The reason for the discrepancy between their results and ours is not clear. It is possible that R-Ras is able to function as either an inhibitor or a promoter of cell death, depending on cell types.
It has been reported that integrins are involved in regulation of cell death (Ruoslahti and Reed, 1994) . Furthermore, R-Ras has been shown to be implicated in modulation of integrins (Zhang et al., 1996) . However, R-Ras did not require integrin ligands such as ®bronectin, vitronectin or laminin to suppress cell death of BaF3. In addition, the RGD peptide showed no inhibitory eect on the suppression by R-Ras in the IL-3-free medium (data not shown). Therefore, it is likely that R-Ras suppressed BaF3 cell death in an integrin-independent manner. However, we microscopically observed aggregation of BaF3 cells in response to R-Ras(Q87L) expression (data not shown). This may suggest that R-Ras somehow regulates cell-cell adhesion in this cell. The mechanism of R-Ras-induced adhesion and its relationship with R-Ras-induced celldeath suppression is currently under investigation.
Materials and methods
Materials
Plasmid pUC12-R-ras and a polyclonal antibody to human R-Ras were kindly provided by David Goeddel (Genentech Inc., South San Francisco, CA). Mouse IL-3 and IL-4 were generous gifts of Atsushi Miyajima and Satish Menon (DNAX Research Institute, Palo Alto, CA). PD98059 was a gift from Stuart Decker (Parke-Davis Pharmaceutical Research, Ann Arbor, MI). IGF-I and vitronectin were purchased from Gibco; ®bronectin, PD98059, wortmannin, and LY294002 from Calbiochem; anti-HA antibody (12CA5) from Boehringer Mannheim; anti-human IGF-I antibody (#05-172) from Upstate Biotechnology; anti-FLAG antibody (M2) from Eastman Kodak; anti-R-Ras antibody (#15626E) from Pharmingen (San Diego, CA). pHA-ERK2 was generously provided by Michael Karin (University of California, San Diego).
Molecular constructs of R-ras
Mouse R-ras cDNA fragment was ampli®ed by polymerase chain reaction from pUC12-R-ras and inserted into pUC118 at the HindIII/SalI sites. Mutations were then introduced into the R-ras cDNA by oligonucleotidedirected mutagenesis. All mutations were con®rmed by sequencing. The wild-type and mutant R-ras cDNAs were subcloned into the HindIII-and SalI-digested pCMV5 (Andersson et al., 1989) and the NotI-digested pOPRSVI-CAT (Stratagene) for mammalian expression. For expression of FLAG-R-Ras, the synthetic oligonucleotides encoding the FLAG epitope (Asp-Tyr-Lys-Asp-Asp-AspAsp-Lys) were cloned into the MluI/HindIII sites of pCMV5 to generate pCMV5-FLAG, and the cDNAs of the wild-type and mutant R-ras were subcloned into the HindIII/SalI sites of pCMV5-FLAG.
Cell culture and transfections
BaF3 cells were maintained in the culture medium, RPMI1640 supplemented with 10% (v/v) fetal bovine serum (FBS) and mouse IL-3. For transfectants, G418 (1 mg/ml) and hygromycin (1 mg/ml) were included in the culture medium. The`serum-free medium', a mixture of RPMI1640 and Iscove's modi®ed Dulbecco's medium containing L-glutamate, sodium pyruvate, transferrin, linoleic acid, cholesterol and L-a-phosphatidylcholine, was prepared as described (Cormier et al., 1991) . HEK293 cells were cultured in Dulbecco's modi®ed Eagle medium (DMEM) supplemented with 10% (v/v) FBS.
For stable transfections, 15 mg of pOPRSVI-R-Ras (G38V), pOPRSVI-R-Ras (Q87L), pOPRSVI-R-Ras (S43N), or pOPRSVI-R-Ras was introduced into 1610 7 BaF3 cells with 30 mg of p3'SS (Stratagene) by electroporation. Then transfectants were isolated using G418 (1.5 mg/ml) and hygromycin (1.0 mg/ml). For transient expression, subconuent HEK293 cells were transfected by calcium phosphate coprecipitation. HEK293 cells were exposed to DNA precipitates for 24 h in DMEM containing 10% (v/v) FBS and then starved for one day in DMEM containing 1 mg/ml bovine serum albumin.
MTT assay
For MTT assay, cells were seeded in 96-well plates at 2610 4 cells per well and IPTG was added to each well at a ®nal concentration of 5 mM. In addition, if necessary, reagents such as inhibitors, IGF-I and an anti-IGF-I antibody were also added. In the case of IPTG-treated cells, cells were pretreated with 5 mM IPTG for 12 h in the culture medium prior to all assays. Cells were cultured for various times and then colorimetric assay for cell survival and proliferation using MTT was performed according to manufacturer's instructions (Chemicon International, Temecula, CA).
DNA fragmentation
Fragmentation of the chromosomal DNA on IL-3 deprivation in BaF3 cells was assayed as follows. BaF3 cells (1610 5 ) were solubilized in 450 ml of 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 10 mM NaCl, 0.5% (v/v) Triton X-100. After 10 min incubation on ice, samples were pelleted by centrifugation (15 000 g). DNA fragments in the supernatants were puri®ed by ethanol precipitation following phenol/chloroform extraction, and separated by agarose gel electrophoresis (2% (w/v) agarose). Then, the gel was treated with ribonuclease A (100 mg/ml) and stained with ethidium bromide.
MAPK assay
HEK293 cells were transfected with pHA-ERK2 together with either pCMV5, pCMV5-R-Ras(Q87L), or pCMV5-RRas. After one-day starvation, cells were lysed with buer A (20 mM HEPES-NaOH, pH 7.2, 150 mM KCl, 10% (v/v) glycerol, 0.5% (v/v) Triton X-100, 10 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 10 mM NaF, 1 mM Na 3 VO 4 , 25 mM b-glycerophosphate, 20 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml pepstatin A). For IGF-I stimulation, transfected cells were incubated with 100 ng/ml of IGF-I at 258C for 10 min after serum starvation and lysed. MAPK in vitro kinase assay was performed by the published procedure (Aronheim et al., 1994) . Brie¯y, HA-ERK2 was immunoprecipitated with 0.3 mg of anti-HA antibody from 200 mg of lysate. After washing, the precipitate was incubated at 308C for 20 min with 0.3 mg of myelin basic protein (Sigma) in the presence of 20 mM [g-32 P]ATP (620 TBq/mol) (ICN). The reaction was stopped by boiling in the sample buer for SDS ± PAGE and the samples were resolved by SDS ± PAGE (15%). The radioactivity incorporated into myelin basic protein was measured by an image analyzer (FUJI BAS2000).
PI3K assay
After transfected with either pCMV5, pCMV5-FLAG-RRas(Q87L) or pCMV5-FLAG-R-Ras, HEK293 cells were starved for 1 day and lysed with buer A. PI3K in vitro kinase assay was performed as previously described (Satoh et al., 1993) . Brie¯y, FLAG-R-Ras(Q87L) or FLAG-R-Ras was immunoprecipitated with 0.3 mg of anti-FLAG antibody from 500 mg of lysate. The immunoprecipitate was then mixed with 10 mg of sonicated L-a-phosphatidylinositol (Sigma) and incubated at 258C for 15 min in the presence of 40 mM [g-32 P]ATP (440 TBq/mol). The reaction was terminated by addition of 100 ml of 1 M HCl and 200 ml of chloroform/methanol (1 : 1, v/v). The organic phase was subjected to thin-layer chromatography with silica gel plate and developed with CHCl 3 /CH 3 OH/4N NH 4 OH (9 : 7 : 2, v/v). The radioactivity incorporated into L-a-phosphatidylinositol was quantitated by the image analyzer.
